Results 131 to 140 of about 68,801 (240)

EHA Guidelines on the management of children and adults with hemoglobin SC disease

HemaSphere, Volume 10, Issue 10, October 2026.
Abstract HbSC disease is the second most common type of sickle cell disease (SCD) in populations of African origin. Although it is often grouped together with other types of SCD, particularly sickle cell anemia (HbSS), it has unique pathophysiology and a different spectrum of laboratory and clinical features.
David C. Rees, Valentine Brousse, Mariane de Montalembert, Bart J. Biemond, Lucia De Franceschi, Eugene Oteng‐Ntim, Pagona Flevari, Valeria Pinto, John James, Elena Cela, Stefan Eber, Rachel Kesse‐Adu, Jennifer Knight‐Madden, France Pirenne, Aline Santin, Andreas Glenthøj   +15 more
wiley   +1 more source

Rapid spontaneous regression of a massive post-thrombolysis intracerebral hemorrhage: A case report. [PDF]

Surg Neurol Int
Mdarhri M, Sriri H, Hmamouche OM, Hammoud M, Lakhdar F, Benzagmout M, Chakour K, Faiz Chaoui ME.   +7 more
europepmc   +1 more source

Femoral central venous access during emergency department cardiac arrest and sustained return of spontaneous circulation: 10‐min landmark cohort

Hong Kong Journal of Emergency Medicine, Volume 33, Issue 5, October 2026.
Abstract Background Femoral central venous catheterization (CVC) during ongoing emergency department (ED) cardiopulmonary resuscitation (CPR) may improve medication delivery and influence resuscitation outcomes, but observational comparisons are prone to time‐dependent bias.
Abdullah A. Bakhsh
wiley   +1 more source

Quercetin in Myocardial Ischemia–Reperfusion Injury: Mechanistic Evidence, Cardioprotective Effects, and Translational Challenges

Journal of Biochemical and Molecular Toxicology, Volume 40, Issue 10, October 2026.
Quercetin mitigates myocardial ischemia–reperfusion injury through coordinated antioxidant, anti‐inflammatory, and anti‐apoptotic mechanisms, leading to reduced infarct size and improved cardiac function. Its multi‐target cardioprotective effects highlight quercetin as a promising therapeutic candidate for ischemic heart disease.
Rony Abdi Syahputra, Princella Halim, Sasniwiati Sari Hasibuan, Adhayani Lubis   +3 more
wiley   +1 more source

Early Outcomes of Bolus Thrombolysis Plus Manual Aspiration Thrombectomy Using Conventional Catheters for Intermediate-High- and High-Risk Acute Pulmonary Embolism. [PDF]

J Clin Med
Min G, Hong W, Kwon LM, Do YS, Nam H, Park S, Jo SH, Kim HS.   +7 more
europepmc   +1 more source

A Novel GDF2 Mutation in a Patient With Hereditary Hemorrhagic Telangiectasia Complicated by Acute Cerebral Infarction

eJHaem, Volume 7, Issue 5, October 2026.
ABSTRACT Introduction Hereditary hemorrhagic telangiectasia (HHT) is an autosomal dominant disease and the growth differentiation factor 2 (GDF2) variants have been identified as an infrequent cause of HHT. Case Report We report a 64‐year‐old female patient with an onset of ischemic stroke suspected related with microscopic pulmonary arteriovenous ...
Huaqin Zuo, Lingling Qian, Jian Jing, Lu Wang, Xiaobo Li, Yong Chen, Xuefeng Wang, Qiulan Ding, Jian Gu, Mei Sun   +9 more
wiley   +1 more source

Systemic immune-inflammatory and inflammatory response indices in hemorrhagic transformation of acute ischemic stroke patients undergoing intravenous thrombolysis: A cohort study. [PDF]

Medicine (Baltimore)
Mu J, Deng M, Xu L, Yu J, Peng K.
europepmc   +1 more source

Efficacy of Defibrinogenation Therapy for Sudden Sensorineural Hearing Loss: A Systematic Review and Meta‐Analysis

Laryngoscope Investigative Otolaryngology, Volume 11, Issue 5, October 2026.
ABSTRACT Background Sudden sensorineural hearing loss (SSNHL) is a perplexing medical condition characterized by rapid hearing decline, often accompanied by symptoms such as tinnitus and vertigo. Effectiveness of batroxobin treatment is not clearly known.
Jieun Shin, Jaekwang Lee, Jong Dai Kim, Young Hwa Song, Taeho Greg Rhee, Sung Ryul Shim, Jong‐Yeup Kim   +6 more
wiley   +1 more source

Neutrophil Extracellular Traps in Atherosclerosis and Cardiovascular Disease

MedComm, Volume 7, Issue 10, October 2026.
NETs as integrated effectors in the atherosclerotic cardiovascular disease continuum. Activated neutrophils release NETs that promote endothelial injury, thrombo‐inflammation, and plaque destabilization throughout atherosclerotic disease progression. Created with BioRender.com.
Ji Zhang, Fangjiaqi Wei, Mengdi Qu, Yuwen Shao, Tingye Xu, Darko Stojkov, Hans‐Uwe Simon, Ben Huang, Changhong Miao, Hao Zhang   +9 more
wiley   +1 more source

Comparison of the short-term and long-term effects of AngioJet and AcoStream mechanical catheter thrombolysis on acute iliofemoral vein thrombosis. [PDF]

Clinics (Sao Paulo)
Yang Y, Dong X, Zhao Y, Chen S.
europepmc   +1 more source